Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001437749-22-015003

Options or other derivatives

  • 10% owner sold 300,000 shares at $5.15 ($1,545,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Agajanian Richy 10% owner 2022-06-10 Sale · Stock Option (right to buy) −300,000 $5.15 $1,545,000 296,075 I
Loading xslF345X03/rdgdoc.xml…